Belgium· BE-AMP-SAM662098-00

Eribulin EG 0.44 mg/ml

A eribulin product containing eribulin mesylate, registered in Belgium by EG. The same ATC class is registered in 18 of our 19 countries.

ATC L01XX41

Checked against FAMHP / AFMPS (Belgium) on September 26, 2026

Informational only — not a medical device.

Compare price across countriesPer daily dose · free account Ask the assistant about eribulin mesylateAnswers with sources · free account Check interactionsSeverity free · mechanism on Growth

Where it is registered

Eribulin is registered in 18 of 19 countries.

Countries holding a registration under ATC L01XX41 (eribulin), each read from that country’s own register.

This record: Belgium, from FAMHP / AFMPS (Belgium)
10 of them publish a price we can compare per daily dose

Search eribulin products by name

Eribulin · ATC L01XX41

18 / 19 countries

Belgiumprice
Canada
Czechiaprice
Denmark
Finlandprice
Franceprice
Germany
Icelandprice
Ireland
Japan
Netherlands
Norwayprice
Polandprice
Spainprice
Sweden
Switzerlandprice
United Kingdom
United Statesprice

Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

FAMHP / AFMPS (Belgium)

Active substance: Eribulin Mesylate
Manufacturer: EG
Country: Belgium (BE)
ATC code: L01XX41
ATC class: Eribulin
Defined daily dose: 0.21 mg, P
Reimbursed: Not published by this register
Source register: FAMHP / AFMPS (Belgium)
Last checked: September 26, 2026

Packs & prices · 2

be_apb
7741689
be_apb
4875977

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

428 interactions on record for eribulin.

Graded by severity as the source publishes them — 93 severe. Severity grades are free for everyone; mechanism and management come with Growth.

Severity for every pair — free, no plan needed
The source, licence and sync date on every record
Mechanism and what to do for each pair — Growth plan

Check eribulin against other medicines How interaction checks work

Eribulin · interactions on record

428 records

93 severe
331 moderate
4 minor

Most severe, free to view

PapaverineA03AD01severe
CisaprideA03FA02severe
DolasetronA04AA04severe
QuinidineC01BA01severe

Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.

Mechanism and what to do, in the interaction check

Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Eribulin in 16 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All eribulin products

Authorised across Europe · EMA

The same active substance is authorised in 29 EEA countries. Names it is sold under:

Austria · Eribulin Accord, Eribulin Advanz Pharma
Bulgaria · Eribulin Ever Pharma, Sclarint
Czechia · Erhopana, Eribulin Accord
Germany · Eribulin Aqvida, Eribulin Beta
Denmark · Eribulin Accord, Eribulin Ever Pharma
Estonia · Eribulin, Eribulin Accord
Spain · Eribulina, Eribulina Advanz Pharma
Finland · Eribulin, Eribulin Accord
France · Eribuline Accord, Eribuline Advanz Pharma
United Kingdom (Northern Ireland) · Eribulin Dr. Reddy's Laboratories (Uk), Eribulin Glenmark Pharmaceuticals Europe
Greece · Eribulin Ever Pharma
Croatia · Eribulin, Eribulin Accord
Hungary · Eribulin Advz, Eribulin Ever Pharma
Ireland · Eribulin Advanz Pharma, Eribulin Ever Pharma
Iceland · Advz, Eribulin Advanz Pharma
Italy · Eribulina Advanz Pharma, Eribulina Eg
Liechtenstein · Eribulin Baxter, Halaven
Lithuania · Eribulin, Eribulin Accord
Luxembourg · Eribulin Eg
Latvia · Eribulin, Eribulin Advz
Malta · Eribulin Tillomed
Netherlands · Eribulin Ever Pharma, Eribuline Hikma
Norway · Eribulin Accord, Eribulin Advanz Pharma
Poland · Eribulin Ever Pharma
Portugal · Eribulina Advanz Pharma, Eribulina Cttq
Romania · Erhopana, Eribulin Ever Pharma
Sweden · Eribulin, Eribulin Accord
Slovenia · Eribulin Ever Pharma
Slovakia · Eribulin Advz, Eribulin Agmed

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload

GET /v1/drugs/b896f9b1-6fcc-4f76-b424-77b4636017ff
GET /v1/drugs/b896f9b1-6fcc-4f76-b424-77b4636017ff?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Solution for injection",
  "source": "afmps",
  "status": "AUTHORIZED",
  "name_en": "Eribulin EG 0.44 mg/ml",
  "name_fr": "Eribulin EG 0.44 mg/ml",
  "name_nl": "Eribulin EG 0.44 mg/ml",
  "amp_code": "SAM662098-00",
  "strengths": [
    "0.5000",
    "0.5000",
    "0.4400",
    "0.4400",
    "39.4600",
    "0.0000"
  ],
  "pack_count": 2,
  "substances": [
    "Eribulin Mesylate",
    "Eribulin",
    "Anhydrous Ethanol",
    "Sodium Hydroxide"
  ],
  "medicine_type": "ALLOPATHIC",
  "atc_description": "Eribulin",
  "authorisation_numbers": [
    "BE662098"
  ]
}

API reference MCP server Plans

See everything about eribulin.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it free Open in the console